Cell Therapy Technologies Market
Dublin, Dec. 08, 2022 (GLOBE NEWSWIRE) -- The "Cell Therapy Technologies Market Share, Size, Trends, Industry Analysis Report, By Product; By Process; By Cell Type; By End-Use; By Region; Segment Forecast, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
The global cell therapy technologies market size is expected to reach USD 12.27 billion by 2030, according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.
The development of cutting-edge cellular therapy technologies has been made possible by the emergence of new technologies. Companies are using new technologies to boost their product development plans by entering into out-licensing or co-development agreements with other parties in addition to expanding their product line.
Researchers are investing a lot of money in the creation of such efficient and secure treatments as an alternative to traditional treatment modalities, which is another factor contributing to the industry expansion. Oncology has the most active clinical trials out of all therapeutic specialties. For clinical research, T cells, CD34+ and/or CD133+ stem cells, and mesenchymal stem/stromal cells are primarily used.
Additionally, a component that was negatively impacted in 2020, further impacting industry growth, is the requirement for successful commercial translation of cell-based therapy technologies. This factor requires large and stable funding.
Cell therapy Technologies Market Report Highlights
Cell therapy equipment segment is anticipated to grow at an escalating over the forecast period owing to act of replacing, mending, restoring, or regenerating damaged tissues, cells, and organs, cell-based therapies have significant potential.
Cell processing accounted for largest of the global revenue share which is due to increased Viral vectors are now the primary delivery modality among end users, as seen by the exponential rise in the number of viral vector-based R&D initiatives.
Stem cells sector is expected to grow during the forecast period. This growth is attributed to increased research and development initiatives taken.
Research institutes and cell banks sector accounted for the largest revenue share over the forecast period due to the widespread of lymphatic and neuro stimulated disorders and researches in accordance to develop a cure for it.
North America is expected to grow at a significant CAGR over the projected period on account of fast acting insulin demand in the region is being driven by rising diabetes rates and an aging population.
No. of Pages
2022 - 2030
Estimated Market Value (USD) in 2022
Forecasted Market Value (USD) by 2030
Compound Annual Growth Rate
The publisher has segmented the cell therapy technologies market report based on product, process, cell type, end-use, and region:
Long-acting insulin, Product Outlook (Revenue - USD Billion, 2022 - 2030)
Media, Sera, and Reagents
Cell Engineering Products
Cell Culture Vessels
Cell Therapy Equipment
Cell Processing Equipment
Systems and Software
Long-acting insulin, Process Outlook (Revenue - USD Billion, 2022 - 2030)
Distribution and Handling
Process Monitoring and Quality Control
Long-acting insulin, Cell Type Outlook (Revenue - USD Billion, 2022 - 2030)
Long-acting insulin, End-Use Channel Outlook (Revenue - USD Billion, 2022 - 2030)
Biopharmaceutical and Biotechnology Companies
CROs and CMOs
Research Institutes and Cell Banks
Long-acting insulin, Regional Outlook (Revenue - USD Billion, 2022 - 2030)
Middle East & Africa
Key Topics Covered:
2. Executive Summary
3. Research Methodology
4. Global Cell Therapy Technologies Market Insights
5. Global Cell Therapy Technologies Market, by Product
6. Global Cell Therapy Technologies Market, by Process
7. Global Cell Therapy Technologies Market, by Cell Type
8. Global Cell Therapy Technologies Market, by End-Use
9. Global Cell Therapy Technologies Market, by Geography
10. Competitive Landscape
11. Company Profiles
Thermo Fisher Scientific Inc.
Becton Dickinson and Company
For more information about this report visit https://www.researchandmarkets.com/r/idd2uq
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900